Primary Catalyst Driving Drug And Gene Delivery Devices Market Evolution in 2025: The Increasing Adoption Of Gene Therapy Propelling The Growth Of The Drug And Gene Delivery Devices Market Driver

"What Is the Future Outlook for the Drug And Gene Delivery Devices Market's Size and Growth Rate?
There has been significant growth in the market size of drug and gene delivery devices in recent years. The market is projected to expand from $0.61 billion in 2024 to $0.67 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.0%. The historical growth can be linked to the development of healthcare infrastructure, the broadening of individualized gene therapy programs, a heightened emphasis on preventive healthcare, the prevalence of rare and orphan diseases, as well as increased public health awareness and knowledge about treatment possibilities.

The market size for drug and gene delivery devices is projected to experience substantial growth in the upcoming years. The market is anticipated to increase to $0.93 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The expanding incidences of chronic diseases, the surge in demand for personalized medicine, the rising comprehension and acceptance of gene therapy, the need for non-intrusive and minor invasive procedures, and the burgeoning popularity of direct-to-patient delivery models are contributing to the growth in the forecast period. The forecast period also considers significant trends such as the progression in biotechnology and genetic engineering, technological enhancements in drug delivery systems, growing investments in research and development, the evolution of innovative delivery platforms, and breakthroughs in diagnostic technologies.

What Is Stimulating Growth in the Drug And Gene Delivery Devices Market?
The drug and gene delivery devices market is predicted to flourish due to the rising implementation of gene therapy. Serving as a medical method, gene therapy delivers, removes, or modifies genetic material in a patient's cells to counter or inhibit diseases. This therapeutic method is gaining popularity due to its inherent ability to address the core of genetic disorders and chronic illnesses, providing revolutionary treatment opportunities beyond the capability of traditional therapies. In the context of gene therapy, drug and gene delivery devices play a crucial role in accurately directing and properly controlling the delivery of therapeutic genes, thereby improving the effectiveness of the treatment. For instance, the National Centre for Biotechnology Information, an American scientific research resource center, stated in November 2023 that the forecasted number of new gene therapy recipients would rise from 16,244 in 2020 to 94,696 in 2025. As such, the escalating implementation of gene therapy is fueling the expansion of the drug and gene delivery devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp

Which Key Market Leaders Are Driving Drug And Gene Delivery Devices Industry Growth?
Major companies operating in the drug and gene delivery devices market are Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Medtronic plc, Amgen Inc., Moderna Inc., Biogen Inc., Sarepta Therapeutics Inc., SCIEX, Halozyme Therapeutics Inc., ViiV Healthcare Limited, Uniqure NV, Cytokinetics Inc., Prothena Corporation plc, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics

What Are the Emerging Trends in the Drug And Gene Delivery Devices Industry?
Key players in the drug and gene delivery devices market are concentrating on creating cutting-edge products like artificial intelligence (AI) technology to secure a strong hold in the market. AI technology in drug delivery is the utilization of AI methods to enhance the accuracy, effectiveness, and efficiency of drug delivery systems. For instance, Envoya Inc., a US-based company specializing in the creation of polymer-based nanoparticles devised a new gene therapy drug delivery platform in December 2023. The platform harnesses the power of AI with biopolymer-nanoparticles to handle notable shortcomings in present gene therapy methodologies, including viral vectors and lipid nanoparticles. The end goal of this platform is to overcome the barriers faced by current gene therapy delivery technologies constrained by safety issues, restricted cargo capacity, and confined tissue targeting.

What Are the Main Segments in the Drug And Gene Delivery Devices Market?
The drug and gene delivery devicesmarket covered in this report is segmented -

1) By Vector: Viral, Non-viral
2) By Method: In Situ, Ex Vivo
3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical

Subsegments:
1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors
2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/drug-and-gene-delivery-devices-global-market-report

Which Geographic Area Leads the Drug And Gene Delivery Devices Market?
North America was the largest region in the drug and gene delivery devices market in 2024. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Drug And Gene Delivery Devices Global Market Report?

- Market Size Analysis: Analyze the Drug And Gene Delivery Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Drug And Gene Delivery Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Drug And Gene Delivery Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Drug And Gene Delivery Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19404"

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.